The present study identified α5-nAChR as a regulator mediating the tumorigenesis effects of low-dose nicotine on lung adenocarcinoma in aspects of proliferation, migration, epithelial-mesenchymal transition, and EGFR pathway activation (Figure 6I). Here, EGFR is linked to lung adenocarcinoma.